Dexcom (DXCM) Cash & Current Investments (2010 - 2026)
Dexcom (DXCM) posted quarterly Cash & Current Investments of $1.1 billion for Q2 2026, down 4.66% year-over-year from $1.2 billion in Q2 2025, and down 1.18% quarter-over-quarter from $1.1 billion in Q1 2026.
Dexcom (DXCM) Cash & Current Investments (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Cash & Current Investments for 17 consecutive years, with $1.1 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash & Current Investments fell 4.66% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (down 4.66% YoY), while the FY2025 annual figure was $917.7 million, down 64.42% from the prior year.
- Cash & Current Investments slipped to $1.1 billion in Q2 2026 per DXCM's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Cash & Current Investments topped out at $3.6 billion in Q2 2023 and bottomed at $917.7 million in Q4 2025.
- Historically, Cash & Current Investments has averaged $2.4 billion across 5 years, with a median of $2.6 billion in 2023.
- Annual changes were most pronounced in 2023 — Cash & Current Investments jumped 36.61% — and 2025, when it sank 64.42%.
- Dexcom's Cash & Current Investments stood at $2.5 billion in 2022, then climbed by 10.91% to $2.7 billion in 2023, then fell by 5.31% to $2.6 billion in 2024, then tumbled by 64.42% to $917.7 million in 2025, then climbed by 20.41% to $1.1 billion in 2026.
- Business Quant data shows DXCM's Cash & Current Investments at $1.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $917.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.20 Bn | 18.79 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Bn |
| Mar 31, 2026 | 1.12 Bn |
| Dec 31, 2025 | 917.70 Mn |
| Sep 30, 2025 | 1.37 Bn |
| Jun 30, 2025 | 1.16 Bn |
| Mar 31, 2025 | 2.70 Bn |
| Dec 31, 2024 | 2.11 Bn |
| Sep 30, 2024 | 2.49 Bn |
| Jun 30, 2024 | 3.12 Bn |
| Mar 31, 2024 | 2.90 Bn |
| Dec 31, 2023 | 2.72 Bn |
| Sep 30, 2023 | 3.24 Bn |
| Jun 30, 2023 | 3.64 Bn |
| Mar 31, 2023 | 2.57 Bn |
| Dec 31, 2022 | 2.46 Bn |
| Sep 30, 2022 | 2.37 Bn |
| Jun 30, 2022 | 2.75 Bn |
| Mar 31, 2022 | 2.69 Bn |
| Dec 31, 2021 | 2.73 Bn |
| Sep 30, 2021 | 2.70 Bn |